Roadmaps to regulation : MDMA

Moore, K; Wells, H; Feilding, A

Abstract

As we enter the fourth decade of MDMA’s widespread use, new thinking is needed on how to better control production and distribution, and on how to reduce the risks associated with its consumption. There is growing evidence to support reorienting drug policy away from an ideologically driven criminal justice-led model to one rooted in pragmatic health and harm reduction principles. Current policy is not meeting its goal of reducing harms, and greater control of MDMA production, distribution, purchase, and consumption is needed in order to prevent MDMA-related emergencies.

This policy proposal examines the acute, sub-acute, and chronic harms related to MDMA use in detail. We examine the production, distribution, purchase, and consumption of the drug; related risks and harms; and the impact prohibition has on these, as well as the potential impact of alternative policies. Crucially, our evidence shows that most harms associated with MDMA use arise from its unregulated status as an illegal drug, and that any risks inherent to MDMA could be more effectively mitigated within a legally regulated market.

Citation

Moore, K., Wells, H., & Feilding, A. (2019). Roadmaps to regulation : MDMA

• Report Type: Project Report
• Publication Date: Dec 5, 2019
• Deposit Date: Dec 13, 2019
• Publicly Available Date: Dec 13, 2019
• Series Title: Roadmaps to Regulation
• ISBN: 9781907072048
• Publisher URL: https://beckleyfoundation.org/mdma-report/
• Related Public URLs: https://beckleyfoundation.org/
• Additional Information: Funders : John Paul Getty Jr. Foundation;Open Society Foundations (OSF);Tides Foundation;Flora Family Foundation